FDA, cancer and Blood Pressure
Digest more
The U.S. Food and Drug Administration (“FDA”) announced the launch of its “Green List” initiative designed to protect consumers from illegally imported GLP-1 drug ingredients—such as semaglutide and tirzepatide—on September 5, 2025. According ...
Additional ground cinnamon products were the subject of an Oct. 30 recall notice from the FDA. Affected products contained "elevated" levels of lead.